216 related articles for article (PubMed ID: 24268522)
1. Chromosome instability and carcinogenesis: insights from murine models of human pancreatic cancer associated with BRCA2 inactivation.
Cassidy LD; Liau SS; Venkitaraman AR
Mol Oncol; 2014 Mar; 8(2):161-8. PubMed ID: 24268522
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of Brca2 cooperates with Trp53(R172H) to induce invasive pancreatic ductal adenocarcinomas in mice: a mouse model of familial pancreatic cancer.
Feldmann G; Karikari C; dal Molin M; Duringer S; Volkmann P; Bartsch DK; Bisht S; Koorstra JB; Brossart P; Maitra A; Fendrich V
Cancer Biol Ther; 2011 Jun; 11(11):959-68. PubMed ID: 21455033
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of Brca2 promotes Trp53-associated but inhibits KrasG12D-dependent pancreatic cancer development in mice.
Rowley M; Ohashi A; Mondal G; Mills L; Yang L; Zhang L; Sundsbak R; Shapiro V; Muders MH; Smyrk T; Couch FJ
Gastroenterology; 2011 Apr; 140(4):1303-1313.e1-3. PubMed ID: 21199651
[TBL] [Abstract][Full Text] [Related]
4. BRCA2 and pancreatic cancer.
Naderi A; Couch FJ
Int J Gastrointest Cancer; 2002; 31(1-3):99-106. PubMed ID: 12622420
[TBL] [Abstract][Full Text] [Related]
5. Possible causes of chromosome instability: comparison of chromosomal abnormalities in cancer cell lines with mutations in BRCA1, BRCA2, CHK2 and BUB1.
Grigorova M; Staines JM; Ozdag H; Caldas C; Edwards PA
Cytogenet Genome Res; 2004; 104(1-4):333-40. PubMed ID: 15162061
[TBL] [Abstract][Full Text] [Related]
6. Targeting reactive nitrogen species suppresses hereditary pancreatic cancer.
Li M; Chen Q; Ma T; Yu X
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7106-7111. PubMed ID: 28630313
[TBL] [Abstract][Full Text] [Related]
7. Family history of cancer and germline BRCA2 mutations in sporadic exocrine pancreatic cancer.
Real FX; Malats N; Lesca G; Porta M; Chopin S; Lenoir GM; Sinilnikova O;
Gut; 2002 May; 50(5):653-7. PubMed ID: 11950811
[TBL] [Abstract][Full Text] [Related]
8. Cancer suppression by the chromosome custodians, BRCA1 and BRCA2.
Venkitaraman AR
Science; 2014 Mar; 343(6178):1470-5. PubMed ID: 24675954
[TBL] [Abstract][Full Text] [Related]
9. Germline Brca2 heterozygosity promotes Kras(G12D) -driven carcinogenesis in a murine model of familial pancreatic cancer.
Skoulidis F; Cassidy LD; Pisupati V; Jonasson JG; Bjarnason H; Eyfjord JE; Karreth FA; Lim M; Barber LM; Clatworthy SA; Davies SE; Olive KP; Tuveson DA; Venkitaraman AR
Cancer Cell; 2010 Nov; 18(5):499-509. PubMed ID: 21056012
[TBL] [Abstract][Full Text] [Related]
10. How do mutations affecting the breast cancer genes BRCA1 and BRCA2 cause cancer susceptibility?
Venkitaraman AR
DNA Repair (Amst); 2019 Sep; 81():102668. PubMed ID: 31337537
[TBL] [Abstract][Full Text] [Related]
11. EMSY overexpression disrupts the BRCA2/RAD51 pathway in the DNA-damage response: implications for chromosomal instability/recombination syndromes as checkpoint diseases.
Cousineau I; Belmaaza A
Mol Genet Genomics; 2011 Apr; 285(4):325-40. PubMed ID: 21409565
[TBL] [Abstract][Full Text] [Related]
12. Context dependence of checkpoint kinase 1 as a therapeutic target for pancreatic cancers deficient in the BRCA2 tumor suppressor.
Hattori H; Skoulidis F; Russell P; Venkitaraman AR
Mol Cancer Ther; 2011 Apr; 10(4):670-8. PubMed ID: 21289082
[TBL] [Abstract][Full Text] [Related]
13. Tumour suppressor mechanisms in the control of chromosome stability: insights from BRCA2.
Venkitaraman AR
Mol Cells; 2014 Feb; 37(2):95-9. PubMed ID: 24598993
[TBL] [Abstract][Full Text] [Related]
14. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.
Vos S; Vesuna F; Raman V; van Diest PJ; van der Groep P
Oncotarget; 2015 Oct; 6(31):32115-37. PubMed ID: 26378051
[TBL] [Abstract][Full Text] [Related]
15. The phospho-dependent role of BRCA2 on the maintenance of chromosome integrity.
Ehlén Å; Sessa G; Zinn-Justin S; Carreira A
Cell Cycle; 2021 Apr; 20(8):731-741. PubMed ID: 33691600
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic acinar cell carcinoma is associated with
Kryklyva V; Haj Mohammad N; Morsink FHM; Ligtenberg MJL; Offerhaus GJA; Nagtegaal ID; de Leng WWJ; Brosens LAA
Cancer Biol Ther; 2019; 20(7):949-955. PubMed ID: 31002019
[TBL] [Abstract][Full Text] [Related]
17. WRN rescues replication forks compromised by a BRCA2 deficiency: Predictions for how inhibition of a helicase that suppresses premature aging tilts the balance to fork demise and chromosomal instability in cancer.
Datta A; Brosh RM
Bioessays; 2022 Aug; 44(8):e2200057. PubMed ID: 35751457
[TBL] [Abstract][Full Text] [Related]
18. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
Goggins M; Schutte M; Lu J; Moskaluk CA; Weinstein CL; Petersen GM; Yeo CJ; Jackson CE; Lynch HT; Hruban RH; Kern SE
Cancer Res; 1996 Dec; 56(23):5360-4. PubMed ID: 8968085
[TBL] [Abstract][Full Text] [Related]
19. DNA recombination, chromosomal stability and carcinogenesis: insights into the role of BRCA2.
Shivji MK; Venkitaraman AR
DNA Repair (Amst); 2004; 3(8-9):835-43. PubMed ID: 15279768
[TBL] [Abstract][Full Text] [Related]
20. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
